Therapeutic combination of a VEGF antagonist (VEGF trap) and an antihypertensive agent

Details for Australian Patent Application No. 2006213856 (hide)

International Classifications

Event Publications

30 August 2007 PCT application entered the National Phase

PCT publication WO2006/086544 Priority application(s): WO2006/086544

17 March 2011 Application Accepted

Published as AU-B-2006213856

14 July 2011 Standard Patent Sealed

6 September 2012 Extension of Term of Standard Patents

Regeneron Pharmaceuticals, Inc. The earliest first regulatory approval date provided by the patentee 07 Mar 2012 For the goods EYLEA aflibercept

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.